Harry E. Carmitchel
2008
In 2008, Harry E. Carmitchel earned a total compensation of $329.3K as Former Chief Operating Officer at Osiris Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Option Awards | $118,994 |
| Salary | $180,260 |
| Total | $329,254 |
Carmitchel received $180.3K in salary, accounting for 55% of the total pay in 2008.
Carmitchel also received $30K in bonus and $119K in option awards.
Rankings
In 2008, Harry E. Carmitchel's compensation ranked 7,684th out of 9,135 executives tracked by ExecPay. In other words, Carmitchel earned more than 15.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,684 out of 9,135 | 16th |
Division Manufacturing | 2,912 out of 3,436 | 15th |
Major group Chemicals And Allied Products | 674 out of 815 | 17th |
Industry group Drugs | 485 out of 597 | 19th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 118 | 24th |
Source: SEC filing on April 16, 2010.
Carmitchel's colleagues
We found five more compensation records of executives who worked with Harry E. Carmitchel at Osiris Therapeutics in 2008.
2008
C Mills
Osiris Therapeutics
Chief Executive Officer
2008
Richard Hunt
Osiris Therapeutics
Chief Financial Officer
2008
Therapeutics Williams
Osiris Therapeutics
Chief Scientific Officer
2008
Lode Debrabandere
Osiris Therapeutics
Senior Vice President,
2008
Philip Jacoby
Osiris Therapeutics